NO20025302L - Aromatase-inhibitorer og monoklonale anti-HER2-antistoffer som antitumormidler - Google Patents
Aromatase-inhibitorer og monoklonale anti-HER2-antistoffer som antitumormidlerInfo
- Publication number
- NO20025302L NO20025302L NO20025302A NO20025302A NO20025302L NO 20025302 L NO20025302 L NO 20025302L NO 20025302 A NO20025302 A NO 20025302A NO 20025302 A NO20025302 A NO 20025302A NO 20025302 L NO20025302 L NO 20025302L
- Authority
- NO
- Norway
- Prior art keywords
- monoclonal anti
- aromatase inhibitors
- antitumor agents
- her2 antibodies
- her2
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57135500A | 2000-05-15 | 2000-05-15 | |
| PCT/EP2001/004468 WO2001087334A1 (en) | 2000-05-15 | 2001-04-19 | Aromatase inhibitors and monoclonal anti-her2 antibodies as antitumors agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20025302L true NO20025302L (no) | 2002-11-05 |
| NO20025302D0 NO20025302D0 (no) | 2002-11-05 |
Family
ID=24283360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20025302A NO20025302D0 (no) | 2000-05-15 | 2002-11-05 | Aromatase-inhibitorer og monoklonale anti-HER2-antistoffer som antitumormidler |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1282440A1 (hu) |
| JP (1) | JP2003533490A (hu) |
| KR (1) | KR20030014223A (hu) |
| CN (1) | CN1429118A (hu) |
| AU (1) | AU784617B2 (hu) |
| BR (1) | BR0110732A (hu) |
| CA (1) | CA2409652A1 (hu) |
| CZ (1) | CZ20023748A3 (hu) |
| EA (1) | EA005931B1 (hu) |
| EE (1) | EE200200622A (hu) |
| HK (1) | HK1054200A1 (hu) |
| HU (1) | HUP0301877A2 (hu) |
| IL (1) | IL152389A0 (hu) |
| MX (1) | MXPA02011194A (hu) |
| NO (1) | NO20025302D0 (hu) |
| NZ (1) | NZ523004A (hu) |
| PL (1) | PL360153A1 (hu) |
| SK (1) | SK16022002A3 (hu) |
| WO (1) | WO2001087334A1 (hu) |
| ZA (1) | ZA200209815B (hu) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA9811162B (en) | 1997-12-12 | 2000-06-07 | Genentech Inc | Treatment with anti-ERBB2 antibodies. |
| AUPQ105799A0 (en) | 1999-06-18 | 1999-07-08 | Victor Chang Cardiac Research Institute, The | Cell growth inhibition |
| PL217410B1 (pl) | 2000-05-19 | 2014-07-31 | Genentech Inc | Zastosowanie antagonisty ErbB, antagonista ErbB do zastosowania w metodzie leczenia raka i sposób identyfikacji pacjenta skłonnego do korzystnej odpowiedzi na antagonistę ErbB przy leczeniu raka |
| EP1377298B1 (en) * | 2001-01-26 | 2006-08-30 | Pfizer Italia S.r.l. | Exemestane for treating hormono-dependent disorders |
| GB2375958B (en) | 2001-04-09 | 2005-03-02 | George Margetts | The use of steroids to lower the levels of cortisol |
| US7919098B2 (en) | 2002-03-26 | 2011-04-05 | Zensun ( Shanghai ) Sci & Tech Co., Ltd. | ErbB-3 based methods and compositions for treating neoplasms |
| KR20050059001A (ko) * | 2002-07-01 | 2005-06-17 | 사비언트 파마슈티컬즈 인코퍼레이티드 | 치료적 처리를 위한 조성물 및 방법 |
| FR2844455B1 (fr) * | 2002-09-13 | 2007-12-14 | Lab Francais Du Fractionnement | Traitement des pathologies echappant a la reponse immune par des anticorps optimises |
| KR20080019733A (ko) * | 2004-07-16 | 2008-03-04 | 화이자 프로덕츠 인코포레이티드 | 항-아이지에프-1알 항체를 사용하는 비-혈액학적악성종양에 대한 조합 치료 |
| CN102580084B (zh) | 2005-01-21 | 2016-11-23 | 健泰科生物技术公司 | Her抗体的固定剂量给药 |
| SI1850874T1 (sl) | 2005-02-23 | 2014-01-31 | Genentech, Inc. | Podaljšanje časa za napredovanje bolezni ali za preživetje pri pacientkah z rakom na jajčnikih ob uporabi pertuzumaba |
| WO2007045027A1 (en) | 2005-10-19 | 2007-04-26 | Chavah Pty Ltd | Reduction of side effects from aromatase inhibitors used for treating breast cancer |
| AU2008223069B2 (en) | 2007-03-02 | 2012-12-13 | F. Hoffmann-La Roche Ag | Predicting response to a HER dimerisation inhibitor based on low HER3 expression |
| EP2171090B1 (en) | 2007-06-08 | 2013-04-03 | Genentech, Inc. | Gene expression markers of tumor resistance to her2 inhibitor treatment |
| US9551033B2 (en) | 2007-06-08 | 2017-01-24 | Genentech, Inc. | Gene expression markers of tumor resistance to HER2 inhibitor treatment |
| BRPI0812682A2 (pt) | 2008-06-16 | 2010-06-22 | Genentech Inc | tratamento de cáncer de mama metastático |
| MY152068A (en) | 2009-03-20 | 2014-08-15 | Genentech Inc | Bispecific anti-her antibodies |
| WO2010136569A1 (en) | 2009-05-29 | 2010-12-02 | F. Hoffmann-La Roche Ag | Modulators for her2 signaling in her2 expressing patients with gastric cancer |
| CN102892779B (zh) | 2010-02-18 | 2016-12-21 | 基因泰克公司 | 神经调节蛋白拮抗剂及其在治疗癌症中的用途 |
| WO2011146568A1 (en) | 2010-05-19 | 2011-11-24 | Genentech, Inc. | Predicting response to a her inhibitor |
| EP2643353A1 (en) | 2010-11-24 | 2013-10-02 | Novartis AG | Multispecific molecules |
| JP5766296B2 (ja) | 2010-12-23 | 2015-08-19 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用 |
| CN102068429B (zh) * | 2010-12-28 | 2011-12-14 | 西南大学 | 法倔唑在诱导罗非鱼已分化卵巢转变为功能型精巢中的应用及其诱导方法 |
| CN103890007A (zh) | 2011-08-17 | 2014-06-25 | 霍夫曼-拉罗奇有限公司 | 神经调节蛋白抗体及其用途 |
| US9327023B2 (en) | 2011-10-25 | 2016-05-03 | The Regents Of The University Of Michigan | HER2 targeting agent treatment in non-HER2-amplified cancers having HER2 expressing cancer stem cells |
| SG11201402510TA (en) | 2011-11-30 | 2014-06-27 | Genentech Inc | Erbb3 mutations in cancer |
| WO2013083810A1 (en) | 2011-12-09 | 2013-06-13 | F. Hoffmann-La Roche Ag | Identification of non-responders to her2 inhibitors |
| JP2015514710A (ja) | 2012-03-27 | 2015-05-21 | ジェネンテック， インコーポレイテッド | Ｈｅｒ３阻害剤に関する診断及び治療 |
| WO2014015137A2 (en) * | 2012-07-18 | 2014-01-23 | Angion Biomedica Corp. | Compositions and methods for treating dysproliferative diseases |
| MX363188B (es) | 2012-11-30 | 2019-03-13 | Hoffmann La Roche | Identificación de pacientes con necesidad de coterapia del inhibidor de pd-l1. |
| CN107405353B (zh) | 2014-10-22 | 2021-07-30 | 哈瓦赫治疗有限公司 | 降低乳房摄影乳腺密度和/或乳腺癌风险的方法 |
| WO2017066827A1 (en) | 2015-10-22 | 2017-04-27 | Havah Therapeutics Pty Ltd | Methods of reducing mammographic breast density and/or breast cancer risk |
| EP3454863A1 (en) | 2016-05-10 | 2019-03-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Combinations therapies for the treatment of cancer |
| CN107417791B (zh) * | 2017-08-17 | 2020-09-22 | 合肥瀚科迈博生物技术有限公司 | 抗人ErbB2双特异性抗体、其制备方法及用途 |
| AU2020287392A1 (en) | 2019-06-03 | 2021-12-23 | Havah Therapeutics Pty Ltd | Pharmaceutical formulations and systems for delivery of an androgenic agent and an aromatase inhibitor and methods for use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA9811162B (en) * | 1997-12-12 | 2000-06-07 | Genentech Inc | Treatment with anti-ERBB2 antibodies. |
-
2001
- 2001-04-19 JP JP2001583801A patent/JP2003533490A/ja not_active Withdrawn
- 2001-04-19 CZ CZ20023748A patent/CZ20023748A3/cs unknown
- 2001-04-19 HU HU0301877A patent/HUP0301877A2/hu unknown
- 2001-04-19 CA CA002409652A patent/CA2409652A1/en not_active Abandoned
- 2001-04-19 EP EP01929585A patent/EP1282440A1/en not_active Withdrawn
- 2001-04-19 IL IL15238901A patent/IL152389A0/xx unknown
- 2001-04-19 WO PCT/EP2001/004468 patent/WO2001087334A1/en active IP Right Grant
- 2001-04-19 MX MXPA02011194A patent/MXPA02011194A/es not_active Application Discontinuation
- 2001-04-19 NZ NZ523004A patent/NZ523004A/en unknown
- 2001-04-19 AU AU56309/01A patent/AU784617B2/en not_active Ceased
- 2001-04-19 EA EA200201213A patent/EA005931B1/ru not_active IP Right Cessation
- 2001-04-19 KR KR1020027015223A patent/KR20030014223A/ko not_active Application Discontinuation
- 2001-04-19 EE EEP200200622A patent/EE200200622A/xx unknown
- 2001-04-19 PL PL36015301A patent/PL360153A1/xx not_active Application Discontinuation
- 2001-04-19 SK SK1602-2002A patent/SK16022002A3/sk not_active Application Discontinuation
- 2001-04-19 CN CN01809581A patent/CN1429118A/zh active Pending
- 2001-04-19 BR BR0110732-1A patent/BR0110732A/pt not_active IP Right Cessation
-
2002
- 2002-11-05 NO NO20025302A patent/NO20025302D0/no not_active Application Discontinuation
- 2002-12-03 ZA ZA200209815A patent/ZA200209815B/en unknown
-
2003
- 2003-09-11 HK HK03106504.3A patent/HK1054200A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EE200200622A (et) | 2004-06-15 |
| IL152389A0 (en) | 2003-05-29 |
| SK16022002A3 (sk) | 2003-04-01 |
| AU5630901A (en) | 2001-11-26 |
| JP2003533490A (ja) | 2003-11-11 |
| CZ20023748A3 (cs) | 2003-04-16 |
| NZ523004A (en) | 2004-09-24 |
| CN1429118A (zh) | 2003-07-09 |
| HK1054200A1 (zh) | 2003-11-21 |
| AU784617B2 (en) | 2006-05-18 |
| BR0110732A (pt) | 2003-02-04 |
| PL360153A1 (en) | 2004-09-06 |
| EP1282440A1 (en) | 2003-02-12 |
| EA005931B1 (ru) | 2005-08-25 |
| ZA200209815B (en) | 2003-12-03 |
| EA200201213A1 (ru) | 2003-04-24 |
| HUP0301877A2 (hu) | 2003-09-29 |
| WO2001087334A1 (en) | 2001-11-22 |
| NO20025302D0 (no) | 2002-11-05 |
| KR20030014223A (ko) | 2003-02-15 |
| MXPA02011194A (es) | 2003-03-10 |
| CA2409652A1 (en) | 2001-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20025302L (no) | Aromatase-inhibitorer og monoklonale anti-HER2-antistoffer som antitumormidler | |
| DE60222658D1 (de) | Monoklonaler anti-cd-40-antikörper | |
| NO20031642D0 (no) | Humaniserte anti-LT-O-R-antistoff | |
| DK1501856T3 (da) | Anti-HER2 antistofvarianter | |
| CY2012019I2 (el) | Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20 | |
| NO20033387L (no) | Modifiserte antistoffer og fremgangsmåter for anvendelse | |
| NO20054351D0 (no) | Monoklonalt antistoff og hybridom som produserer dette | |
| IS6982A (is) | Mótefni gegn VLA-1 | |
| DK1390389T3 (da) | Cripto-blokerende antistoffer og anvendelser deraf | |
| NO20032549L (no) | Humaniserte antistoffer som gjenkjenner beta-amyloid-peptid | |
| HUP0300841A3 (en) | Agonist anti-trk-c monoclonal antibodies | |
| NO20044347L (no) | Anti-alfavbeta6-antistoff | |
| IS8115A (is) | Mótefni sem beint er gegn einkjörnungstogefnaprótíni-1 (MCP-1) og notkun theirra | |
| DK1560584T3 (da) | Fab I inhibitorer | |
| NO20035366L (no) | Benzoylsulfonamider og sulfonylbenzamidiner for anvendelse som antitumormidler | |
| NO20034405L (no) | Anti-ostepontin-antistoff og anvendelse derav | |
| DK1478667T3 (da) | Monoklonalt anti-humant tenascin-antistof | |
| DE60223191D1 (de) | Ausgeber für Arzneimittel | |
| AU2003220079A8 (en) | Uses of monoclonal antibody 8h9 | |
| EE200300569A (et) | CD44v6-spetsiifilised antikehad | |
| ATE335203T1 (de) | Test für anti-transglutaminase-antikörper | |
| FI20011055A0 (fi) | Heveiiniä sitovat monoklonaaliset vasta-aineet | |
| FI20020807A0 (fi) | Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita | |
| ITPD20000192A0 (it) | Anticorpi policlonali | |
| GB0121727D0 (en) | Monoclonal antibodies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |